The biotech industry's soaring growth owes much to the flourishing realm of personalized medicine, the rise of orphan drugs, innovative biotech tools, and unwavering government support.
In light of this, fundamentally sound biotech stocks Equillium, Inc. (EQ), Protalix BioTherapeutics, Inc. (PLX), and Incyte Corporation (INCY) could hold great potential as ideal additions to your portfolio at this juncture. Before delving into the highlighted stocks, let's gain a detailed understanding of how these factors are driving the industry's growth.
